Puma BioTech
PBYI7.9550.44% ( -0.035 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Puma BioTech(PBYI) predict that the Revenue is 44.8 M (-2.61%), Beat estimate;the EBIT is -3.8 M (-195%), Beat estimate;the EPS is -0.07 (-216.7%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.04B2.61%
0.04B8.70%
+0.00B6.09%
EBITExceed expectations
-0.00B195.00%
-0.00B207.50%
+0.00B12.50%
EPSExceed expectations
-0.07216.67%
-0.17383.33%
+0.1000166.66%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue53 M
Estimate EBIT2 M
Estimate EPS0.04
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf